Acadia 医疗
ACHC
29.98
-1.06
-3.41%
Acadia 医疗
US · ACHC
#2588 按市值排名
上市于 1970
29.98
-1.06
-3.41%
实时 - 追踪5344个代码 - 心跳于3秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量增加了1家。
- 机构持股总比例下降了3.4个百分点。
机构持股
- 机构持股比例
- 144.31% -3.37pp
- 机构数量
- 370 +1
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund86.74%
Hedge Fund38.92%
Public Company14.68%
Government Pension Fund2.16%
Individual/Insider1.66%
Private Company1.48%
Insurance Company0.15%
主要股东 截至 2026-06-30
BlackRock
16.07% · 14.96M 股
Wellington Management Group
6.15% · 5.73M 股
Vanguard Portfolio Management, LLC
5.77% · 5.37M 股
FMR
5.39% · 5.01M 股
Vanguard Capital Management, LLC
4.96% · 4.62M 股
Deerfield Management Company, L.P.
4.85% · 4.52M 股
Greenlight Capital, Inc.
4.73% · 4.40M 股
UBS Asset Management
4.58% · 4.27M 股
Farallon Capital Management, L.L.C.
4.53% · 4.22M 股
Abrams Bison Investments, L.L.C.
4.47% · 4.17M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 31次买入 · 14次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Reeve Waud | Independent Chairperson | 0.74% |
| Brian Farley | General Counsel | 0.15% |
| John Hollinsworth | Officer | 0.12% |
| Todd Young | Chief Financial Officer | 0.12% |
| William Grieco | Independent Director | 0.10% |
| E. Bissell | Independent Director | 0.06% |
| Wade Miquelon | Independent Director | 0.06% |
| Christopher Hunter | Chief Executive Officer | 0.05% |
| Jason Bernhard | Independent Director | 0.05% |
| Vicky Gregg | Independent Director | 0.05% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-07-25 | Brian Farley | General Counsel | Sale to Issuer | -1,770 | $34.51 |
| 2026-06-25 | Brian Farley | General Counsel | Sale to Issuer | -1,370 | $26.24 |
| 2026-05-05 | Reeve Waud | Independent Chairperson | Other Acquisition | +15,907 | -- |
| 2026-05-05 | E. Bissell | Independent Director | Other Acquisition | +11,831 | -- |
| 2026-05-05 | William Grieco | Independent Director | Other Acquisition | +6,331 | -- |
| 2026-05-05 | Jason Bernhard | Independent Director | Other Acquisition | +11,455 | -- |
| 2026-05-05 | Vicky Gregg | Independent Director | Other Acquisition | +6,331 | -- |
| 2026-05-05 | Daniel Cancelmi | Director | Other Acquisition | +6,331 | -- |
| 2026-05-05 | Ralph Kelly | Independent Director | Other Acquisition | +6,331 | -- |
| 2026-05-05 | Patrice Harris | Director | Other Acquisition | +6,331 | -- |
| 2026-05-05 | Michael Fucci | Independent Director | Other Acquisition | +6,331 | -- |
| 2026-05-04 | Brian Farley | General Counsel | Sale to Issuer | -5,063 | $27.69 |
| 2026-04-30 | David Duckworth | Former Chief Financial Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-04-27 | Brian Farley | General Counsel | Other Acquisition | +37,510 | -- |
| 2026-04-09 | Brian Farley | General Counsel | Other Acquisition | +37,510 | -- |
| 2026-04-09 | Todd Young | Chief Financial Officer | Other Acquisition | +58,799 | -- |
| 2026-03-11 | Daniel Cancelmi | Director | Other Acquisition | +6,625 | -- |
| 2026-03-11 | Daniel Cancelmi | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-02-26 | Brian Farley | General Counsel | Sale to Issuer | -1,915 | $22.29 |
| 2026-01-19 | Debra Osteen | Director | Other Derivative Acquisition | +1,125,000 | $11.68 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
Acadia 医疗 讨论区 0 条评论